It has also been reported to downregulate the expression of α-smooth muscle actin (α-SMA) and transforming growth factor-beta (TGF-β), thereby reducing collagen deposition and mitigating the progression of hepatic fibrosis in models of nonalcoholic steatohepatitis [23]. The gene discussed is ACTA1; the disease is metabolic dysfunction-associated steatohepatitis.